Caerulein, a cholecystokinin-related peptide, depresses somatic function via the vagal afferent system
- 1 September 1983
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 33 (11) , 1045-1050
- https://doi.org/10.1016/0024-3205(83)90659-8
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- Cholecystokinin-octapeptide effects on conditioned-avoidance behavior, stereotypy and catalepsyEuropean Journal of Pharmacology, 1982
- GABA-ergic influence on the crossed extensor reflexLife Sciences, 1982
- Caerulfin and cholecystokinin octapeptide (CCK-8): Sedative and anticonvulsive effects in mice unaffected by the benzodiazepine antagonist Ro 15-1788Neuroscience Letters, 1982
- Cholecystokinin reduces exploratory behavior in micePhysiology & Behavior, 1981
- Anticonvulsant effects of caerulein, cholecystokinin octapeptide (CCK-8) and diazepam against seizures produced in mice by harman, thiosemicarbazide and isoniazidNeuroscience Letters, 1981
- Central depressant effects of caerulein and cholecystokinin octapeptide (CCK-8) differ from those of diazepam and haloperidolNeuropharmacology, 1981
- Sensitive depressant effect of benzodiazepines on the crossed extensor reflex in chloralose-anesthetized ratsLife Sciences, 1981
- Anticonvulsant effects of caerulein and cholecystokinin octapeptide, compared with those of diazepamEuropean Journal of Pharmacology, 1980
- Reflectance of rat brain structures mapped by an optical fiber techniqueJournal of Neuroscience Methods, 1980
- Satiety elicited by cholecystokinin in intact and vagotomized ratsPhysiology & Behavior, 1977